CSL Behring GmbH secures contract for Pharmaceutical products - Agreement in accordance with Section 130c Paragraph 1 SGB V on the granting of discounts for patent-protected drugs with the active ingredients Lonoctocog alfa (Afstyla(r)) and Albutrepenonacog alfa (Idelvion(r))

Germany, Sept. 29 -- Germany based CSL Behring GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - Agreement in accordance with Section 130c Paragraph 1 SGB V on the granting of discounts for patent-protected drugs with the active ingredients Lonoctocog alfa (Afstyla(r)) and Albutrepenonacog alfa (Idelvion(r)). The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....